In this edition, with a hybrid format, it will be possible to follow live one of the largest investment conferences focused on private biotechnology companies, listed companies, both established and emerging, where institutional investors, industry analysts and senior company executives of biotechnology, they will have the opportunity to shape future investment projects and discuss the landscape of the biotechnology industry. In addition, within the framework of the conference, B2B meetings can be held thanks to the partnering tool offered and it will be possible to follow business and country presentations that will present their experiences and their biotechnology industry to the gathered audience.

The Chicago Office will participate in the partnering of the Congress, where it will hold meetings with companies and investors interested in Spain.